Skip to main content
. 2009 Jul 5;9:28. doi: 10.1186/1471-2261-9-28

Table 5.

Relative prevalence of various risk factors with increasing age in males and females presented as univariate and adjusted odds ratios and 95% confidence intervals

Variables Age group Univariate odds ratios Adjusted for body mass index Adjusted for waist circumference Adjusted for waist hip ratio
Males

Smoking 15–19 1.0 1.0 1.0 1.0

20–29 5.3 (3.6–7.0) -- -- --

30–39 16.0 (10.5–21.5) -- -- --

Body mass index ≥ 25 kg/m2 15–19 1.0 -- 1.0 1.0

20–29 1.6 (0.9–2.7) -- -- --

30–39 7.1 (4.5–11.2) -- -- --

Waist:hip ratio > 0.9 15–19 1.0 1.0 -- --

20–29 4.5 (2.7–7.6) -- -- --

30–39 21.1 (12.9–34.2) -- -- --

Hypertension 15–19 1.0 1.0 1.0 1.0

20–29 2.6 (1.2–5.8) 1.7 (0.7–3.9) 1.1 (0.4–2.8) 1.3 (0.5–3.2)

30–39 13.0 (6.9–24.6) 7.4 (3.7–14.8) 3.4 (1.5–7.5) 4.3 (1.9–9.5)

LDL cholesterol ≥ 130 mg/dl 15–19 1.0 1.0 1.0 1.0

20–29 6.4 (3.3–12.2) 5.9 (3.0–11.5) 4.7 (2.4–9.4) 5.4 (2.7–10.9)

30–39 27.4 (15.2–49.6) 22.2 (11.7–42.0) 16.7 (8.2–34.1) 20.1 (9.8–41.3)

Triglycerides ≥ 150 mg/dl 15–19 1.0 1.0 1.0 1.0

20–29 3.7 (1.9–7.1) 2.7 (1.4–5.4) 2.4 (1.2–4.8) 2.6 (1.3–5.1)

30–39 24.2 (13.9–42.1) 19.9 (10.9–36.1) 15.8 (8.2–30.8) 16.8 (8.6–32.6)

HDL cholesterol < 40 mg/dl 15–19 1.0 1.0 1.0 1.0

20–29 2.4 (1.5–3.8) 2.4 (1.5–3.9) 1.9 (1.2–3.3) 1.7 (1.0–2.9)

30–39 15.8 (10.2–24.5) 15.1 (9.3–24.7) 12.9 (7.4–22.6) 10.9 (6.4–18.9)

Total: HDL cholesterol > 4.5 15–19 1.0 1.0 1.0 1.0

20–29 1.6 (1.4–1.9) 1.5 (1.3–1.8) 1.4 (1.1–1.7) 1.4 (1.2–1.7)

30–39 37.9 (22.5–63.9) 32.7 (18.6–57.5) 27.9 (14.8–52.4) 26.8 (14.3–50.3)

Diabetes 15–19 1.0 1.0 1.0 1.0

20–29 4.0 (0.3–64.5) 4.2 (0.3–69.9) 2.6 (1.0–72.3) 2.4 (0.9–67.0)

30–39 50.7 (6.4–403.4) 27.8 (3.2–242.7) 26.2 (1.9–365.8) 19.9 (1.2–336.1)

Metabolic syndrome 15–19 1.0 1.0 1.0 1.0

20–29 37.7 (4.8–298.2) 20.7 (2.5–171.7) 14.3 (1.6–128.4) 17.3 (2.1–148.5)

30–39 168.5 (22.8–1247.1) 95.6 (12.3–741.5) 62.9 (6.4–621.3) 59.1 (6.2–568.1)

Females

Smoking 15–19 1.0 1.0 1.0 1.0

20–29 1.0 -- -- --

30–39 6.3 (5.5–7.1) -- -- --

Body mass index ≥ 25 kg/m2 15–19 1.0 1.0 1.0 1.0

20–29 0.8 (0.5–1.4) -- -- --

30–39 11.3 (7.3–11.5) -- -- --

Waist:hip ratio > 0.8 15–19 1.0 1.0 1.0 1.0

20–29 3.1 (2.2–4.3) -- -- --

30–39 17.2 (11.0–26.8) -- -- --

Hypertension 15–19 1.0 1.0 1.0 1.0

20–29 4.8 (0.9–24.9) 4.5 (0.9–23.7) 3.1 (0.6–16.6) 3.2 (0.6–16.7)

30–39 64.0 (14.9–73.9) 18.2 (4.1–82.9) 10.3 (2.0–52.0) 39.1 (7.9–192.7

LDL cholesterol ≥ 130 mg/dl 15–19 1.0 1.0 1.0 1.0

20–29 1.8 (0.9–3.6) 1.8 (0.9–3.5) 1.6 (0.8–3.2) 1.9 (0.9–3.7)

30–39 19.5 (11.0–34.4) 18.2 (9.5–34.8) 17.2 (8.1–36.7) 19.5 (9.7–39.2)

Triglycerides ≥ 150 mg/dl 15–19 1.0 1.0 1.0 1.0

20–29 0.9 (0.4–2.0) 0.9 (0.4–2.0) 0.8 (0.3–1.8) 0.8 (0.4–1.9)

30–39 10.0 (5.5–18.2) 8.5 (4.3–16.6) 7.0 (3.2–15.1) 8.2 (4.0–16.8)

HDL cholesterol < 40 mg/dl 15–19 1.0 1.0 1.0 1.0

20–29 0.8 (0.6–1.0) 0.8 (0.6–1.0) 0.7 (0.5–0.9) 0.7 (0.6–1.1)

30–39 14.1 (7.5–26.7) 11.9 (6.1–23.2) 10.6 (5.2–21.8) 15.8 (7.8–32.0)

Total: HDL cholesterol > 4.5 15–19 1.0 1.0 1.0 1.0

20–29 1.0 (0.9–1.2) 1.0 (0.8–1.2) 0.9 (0.8–1.1) 0.9 (0.8–1.2)

30–39 6.1 (4.5–8.2) 5.9 (4.3–8.3) 5.3 (3.7–7.6) 5.8 (4.1–8.1)

Diabetes 15–19 1.0 1.0 1.0 1.0

20–29 1.0 1.0 1.0 1.0

30–39 17.4 (1.9–156.5) 17.0 (1.3–217.7) 31.6 (0.6–1605.0) 22.0 (1.0–474.5)

Metabolic syndrome 15–19 1.0 1.0 1.0 1.0

20–29 5.7 (0.6–55.3) 5.2 (0.5–51.1) 2.2 (0.2–23.4) 3.0 (0.3–31.0)

30–39 146.2 (19.9–1027.9) 75.1 (9.7–583.9) 19.7 (2.5–155.3) 48.8 (6.3–378.9)